Acute kidney injury (AKI) is a common complication following orthotopic liver transplantation. It is associated with increased morbidity and mortality, as well as increased healthcare costs. The aetiology of AKI post liver transplantation is multifactorial and understanding these factors is pivotal in developing risk stratification and prevention strategies. This study aims to investigate the preoperative and intraoperative factors that may be associated with AKI in patients undergoing liver transplantation at the Princess Alexandra Hospital, Brisbane, Queensland. In our study, retrospective data of 97 consecutive orthotopic liver transplantations performed between January 2009 and August 2012 were recorded. Univariate and multivariate analyses were performed to investigate the preoperative and intraoperative risk factors for the development of AKI in this cohort. In the cohort of 97 patients who underwent orthotopic liver transplantation, 24 patients (25%) developed postoperative AKI. Univariate analysis demonstrated that high preoperative body mass index and intraoperative noradrenaline use were both associated with AKI. Multivariate analysis demonstrated that high body mass index, high Model for End-stage Liver Disease score and intraoperative noradrenaline use were associated with AKI. Overall mortaility was 4.1% during the study period and was not significantly different between the two groups. The high incidence of AKI following liver transplantation in this study cohort highlights the importance of this issue. This study has identified several potential pre-and intraoperative risk factors, providing a focus for patient surveillance and future research.
Liver transplantation (LT) is a life-saving treatment and is indicated for all causes of end-stage liver disease (ESLD) where the process is irreversible and curable by the procedure 1, 2 . In Australia, LT is governed by the Transplantation Society of Australia and New Zealand, who have determined liver recipient suitability criteria 3, 4 .
Despite the therapeutic intent of LT, serious complications can occur. Acute kidney injury (AKI) is one of the most common complications, especially in the early postoperative period [3] [4] [5] [6] [7] . The incidence is reported at between 11% and 94%, with this wide variation likely being the result of multiple definitions within the literature [8] [9] [10] [11] . Despite advances in the surgical and perioperative care of LT patients, and the advent of drugs with less nephrotoxic side-effects, the incidence of AKI has not declined over the last few decades 12 . Additionally, the introduction of the Model for End-stage Liver Disease (MELD) score has increased the proportion of LT candidates who have pre-existing renal dysfunction, as creatinine is a component of MELD calculation 12 . These patients are particularly at risk of having persistently poor or worsening renal function after LT 12 .
The manifestation of AKI after LT has been documented to correlate with higher mortality, long-term morbidity and increased healthcare costs 6, 8, [11] [12] [13] [14] . The cause of AKI post LT appears to be multifactorial, and a number of studies have examined potential factors, however their individual significance is not sufficiently understood 6, [14] [15] [16] [17] [18] [19] [20] . A model to predict AKI post LT has been proposed by Xu et al 7 , but further study and external validation is required.
The aim of this study was to investigate preoperative and intraoperative factors that may be associated with AKI in patients undergoing LT at the Princess Alexandra Hospital (PAH), Brisbane, Queensland. Risk factors identified by Xu et al 7 were included in the analysis. By examining local data, this study aims to provide a platform for further Australian and international research. The ultimate ambition is to optimise perioperative management of LT patients to preserve kidney function, thereby improving outcomes and reducing healthcare costs.
Materials and methods
A retrospective audit of hospital records was conducted for patients with ESLD who underwent LT between January 2009 and August 2012 at the PAH. Patients with acute hepatic failure and those aged <18 years were excluded. The study was approved by the Metro South Hospital and Health Service Human Research Ethics Committee at the PAH (Approval No.: HREC/12/QPAH/438).
Information was collected from patient charts, eVici (a statewide LT patient information database), AUSLAB (a laboratory results database) and AARK ('automated anaesthetic record keeping', in which vital sign data is imported automatically, and other variables are recorded manually). Laboratory data was analysed onsite at the PAH. Baseline laboratory values were taken to be the last set of values prior to commencing LT.
All patients underwent deceased-donor LT. No split-liver transplants were performed. The 'piggy-back' technique without venovenous bypass was applied for all procedures. This is characterised by preservation of the inferior vena cava and avoidance of retrocaval dissection. Patients received triple immunosuppressive therapy consisting of preoperative methylprednisolone and a purine analogue, with the addition of tacrolimus postoperatively adjusted according to postoperative renal function and plasma tacrolimus levels. Anaesthesia was provided by specialist anaesthetists with extensive experience in LT. Anaesthetic technique, including choice of vasoactive drugs, was not standardised and varied amongst practitioners.
Study parameters and definitions were designated based on the predictive model proposed by Xu et al 7 . Intraoperative hypotension was defined as systolic blood pressure <90 mmHg for >15 minutes. AKI was defined as a serum creatinine >133 µmol/l with an increase of 50% above the baseline and/or the requirement for renal replacement therapy in the first week following LT 7 . Serum creatinine was measured on Beckman DxC800 analysers (Beckman Coulter, Brea, CA, USA) by the onsite PAH laboratory for all patients. Preoperative renal dysfunction was defined as estimated glomerular filtration rate <90 ml/min/1.73m 2 and was automatically calculated on AUSLAB as per Kidney Australia formula. No patient in the study cohort had preoperative end-stage kidney disease (estimated glomerular filtration rate <15 ml/min/1.73m 2 ).
Statistical analysis
Statistics on patient characteristics are presented by number (%), mean (±SD) or median (IQR) as appropriate. A non-parametric feature selection (FS) approach, followed by univariate and multivariate logistic regression modelling approaches, was adopted to evaluate the possible association of various demographic, clinical and biochemical factors with AKI. The FS approach is essentially a data-mining approach to choose a subset of risk factors by eliminating factors with little or no predictive information 21 . FS can significantly improve the comprehensibility of the resulting classifier or predictive models and often builds a model that generalises better to unseen points. Although FS is generally employed with large datasets, the small sample properties of FS are well described in the statistical and data-mining literature 22 .
To evaluate the possible association of age, sex, and the pre-transplant measures of body mass index (BMI), MELD score, sodium, potassium, urea and creatinine with AKI, a multivariate logistic regression model was fitted. Both robust and bootstrapped (b=200) confidence intervals (CIs) of the odds ratios (ORs) were obtained, and hence the significance levels (P-values) 23 .
Results
In the cohort of 97 patients with mean (SD) age 49 (12) years, 69% were male, 6% had pre-existing renal dysfunction, 13% had diabetes mellitus and 17% were identified to have incident hypertension ( Table 1 ). The most common indication for LT was for hepatitis C-related ESLD. Details on anthropometric, clinical and laboratory study parameters are presented in Table 2 , for the whole cohort, and separately by AKI status.
During follow-up (mean duration 43 months), 24 (25%) patients developed AKI. The median time for development of AKI was two days (zero to seven) post-LT, and the median duration of AKI was two days (zero to 630) based on the study definition. As represented by the extended range of duration, a proportion of these patients progressed to chronic kidney disease, but further analysis was outside the scope of this study. In the follow-up period, four patients died. Of the deceased patients, two had developed AKI. One patient developed AKI on day one post-LT, and died on day three without AKI resolving. The other patient developed AKI The individual association of risk factors or covariates with the risk of developing AKI is presented in Table  3 . Higher BMI and the use of noradrenaline appeared to be individually significantly associated with the risk of developing AKI. No other baseline, preoperative or intraoperative factors were found to be individually associated with the risk of developing AKI.
The association of pre-and intraoperative risk factors in additive mode with AKI (multivariate models) are presented in Table 4 . There was a suggestion that a higher BMI was associated with an 18% increased risk of developing AKI (95% CI of OR: 1.00, 1.40, P=0.053). Patients who received noradrenaline had a six-fold increased risk of developing AKI Overweight (BMI ≥25 and <30) and obese patients (BMI ≥30) had a significantly higher risk of developing AKI, compared to normal body weight patients. However, the risk was similar for overweight and obese patients ( Figure  1 ). Although higher MELD score is likely to increase the risk of developing AKI, the risk does not increase significantly for higher MELD scores above 11 (Figure 2) .
The estimated area under the receiver operating characteristic curve with pre-and intraoperative risk factors from the multivariate models were 0.81 (95% CI: 0.78, 0.84) and 0.76 (95% CI: 0.72, 0.80), respectively. The area under the receiver operating characteristic curve with joint association of BMI and MELD score was only 0.70 (95% CI: 0.63, 0.76), clearly showing only marginal contribution of other clinical and laboratory based factors in terms of predicting AKI.
Discussion
AKI post LT is multifactorial, and investigation of these factors is vital to instigating protective strategies. This study examined pre-and intraoperative factors in LT recipients at the PAH, applying predictive factors and study definitions published by Xu et al 7 . Examination of postoperative factors was outside the focus of this paper, but recent literature has renewed interest in the role of immunosuppressive drugs on renal dysfunction after LT 24 .
This study found an incidence of AKI post LT of 25%, which falls within the wide range of reported incidences in the literature (11% to 94%) [8] [9] [10] [11] . This paper defined AKI as a postoperative serum creatinine above 133 µmol/l with an increase of 50% above baseline within the first week post LT. This is in keeping with other literature examining the subject, including Xu et al 7, 15 . Xu et al reported a slightly higher incidence (32.4%), which may reflect higher MELD scores in their study cohort (25±9, [mean±SD]) compared with this cohort (median=13, IQR 10 to 17). A recent study examining AKI post LT by Hilmi et al employed a similar definition of AKI: "a 50% increase in SCr from the baseline (pre-operative value) or a 26.5 μmol/l increase from baseline within 48 h without urine output" 25 . The study reported an incidence of 52%, and further concluded that the development of AKI post LT affected short-and long-term graft survival 25 . Other studies examining AKI post LT defined AKI exclusively as the postoperative requirement for renal replacement therapy: Contreas et al 16 , Sanchez et al 20 and Rueggeberg et al 19 reported an incidence of 17%, 12% and 18.3%, respectively.
The definition of AKI is inconsistent within medical research, and consequently it is difficult to compare or consolidate results. To aid future research, it would be prudent to utilise a standardised definition for AKI such as that used by the Risk, Injury, Failure, Loss and End-stage (RIFLE) kidney disease classification, Acute Kidney Injury Network staging, or Kidney Disease Improving Global Outcomes practice guidelines.
Recently it has been questioned whether other markers may be more accurate than creatinine in monitoring renal function post LT. Patients with ESLD have low serum creatinine levels due to reduced muscle mass, malnutrition and decreased creatinine biosynthesis 3 . Consequently, creatinine is recognised to overestimate renal function in patients with ESLD 26 , therefore the inclusion of serum creatinine in the calculation of the MELD score has been questioned. Novel biomarkers such as cystatin C 26 and neutrophil gelatinase-associated lipocalin 18 may be superior to creatinine for the early detection of AKI post LT. Despite Within the study cohort, patients who developed AKI post LT were found to have significantly lower albumin and higher INR on preoperative blood results. Both low albumin and high INR are correlated with poorer liver function, but may also be related to other factors such as poor nutritional status 27 . Low preoperative albumin has been shown to be a prognostic factor in ESLD, and has also been shown in studies to be associated with a greater incidence of AKI post LT 28 . It has been postulated that hypoalbuminaemia may reduce glomerular filtration rate by modifying Starling forces, and may also alter the pharmacokinetics of potentially nephrotoxic drugs 28 .
Amongst other preoperative factors, high BMI was also associated with increased risk of AKI in this population, which is consistent with observations by Himli et al 25 .
The MELD score is a well-recognised scoring system used in priority allocation of LT, in which patients with higher MELD scores are prioritised for earlier transplantation. This practice has been demonstrated to reduce waitlist mortality and reduce waiting times 29 . MELD is calculated using values for serum bilirubin, serum creatinine and INR 29 . While the distribution of preoperative MELD scores was not significantly different between AKI and no-AKI groups, further multivariate analysis of preoperative factors found higher MELD scores to be associated with an increased risk of developing AKI. When analysed individually, serum creatinine was not associated with AKI in this population. This supports observations by Romano et al that, while high MELD scores showed good performance in predicting AKI, serum creatinine alone was not significantly associated with AKI post LT, despite its inclusion in MELD calculation 24 . Further research into the association of MELD with post LT complications is warranted to assist healthcare planning.
Analysis of intraoperative factors within this cohort found the use of intraoperative noradrenaline to be strongly associated with the development of AKI post LT. Noradrenaline use is likely to indicate haemodynamic instability, potentially leading to renal hypoperfusion and thus renal dysfunction. However, no association was found with intraoperative hypotension status, blood loss, urine output, or blood product use in this cohort. It is possible that noradrenaline use may have prevented more sustained hypotension, thus masking the association of intraoperative hypotension. Furthermore, the definition of intraoperative hypotension used in this study and by Xu et al 7 , (systolic blood pressure <90 mmHg for >15 minutes) does not take into account individual patients' baseline blood pressures, and may exclude shorter periods of haemodynamically significant hypotension.
There are conflicting findings within current literature with regard to the association of adrenergic vasopressor agents and the development of AKI post LT. Xu et al found intraoperative noradrenaline to be associated with a reduced incidence of AKI 7 . Conversely, Cabezuelo et al demonstrated that patients who developed AKI post LT had a proportionally higher need for intraoperative blood products and adrenergic agonists 28 . Several studies have reviewed the effects of different vasoactive substances on renal perfusion pressure in non-liver transplant settings, and found no evidence that noradrenaline increases the risk of developing AKI [30] [31] [32] . Moreover, noradrenaline has been suggested to have a protective role in hypotensive vasodilated patients in restoring blood pressure within autoregulatory values 33 . In reality, renal haemodynamics in the liver transplant setting may be more complex than what is currently understood. Further study into this area is warranted, particularly a closer examination of the anhepatic and post anhepatic stages of LT.
Conclusion
The high incidence of AKI post LT reported in this study (25%) and other studies highlights the importance of this issue. While this study is limited by its small sample size and its single-centre, retrospective nature, it also benefits from having a uniform patient population in terms of preoperative workup, surgical technique and immunosuppressive therapy. The risk factors identified provide a focus for further research, which should ultimately aim to improve perioperative management of LT patients. A multi-centre prospective study should be conducted, which should employ a universally recognised definition of AKI, and examine the predictive value of postoperative factors. As the field of transplant medicine continues to expand, ongoing research will ensure the best possible outcomes for patients whilst reducing healthcare costs.
